Vitrolife AB (publ)
VTRLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28,089,868 | $18,134,528 | $27,263,843 | $61,424,756 |
| - Cash | $1,135,000 | $861,000 | $578,000 | $630,094 |
| + Debt | $2,089,000 | $2,089,000 | $2,225,000 | $2,482,494 |
| Enterprise Value | $29,043,868 | $19,362,528 | $28,910,843 | $63,277,156 |
| Revenue | $3,609,000 | $3,512,000 | $3,234,000 | $1,680,804 |
| % Growth | 2.8% | 8.6% | 92.4% | – |
| Gross Profit | $2,139,000 | $1,978,000 | $1,780,000 | $1,046,090 |
| % Margin | 59.3% | 56.3% | 55% | 62.2% |
| EBITDA | $1,159,000 | -$3,193,000 | $977,000 | $579,000 |
| % Margin | 32.1% | -90.9% | 30.2% | 34.4% |
| Net Income | $513,000 | -$3,851,000 | $394,000 | $341,000 |
| % Margin | 14.2% | -109.7% | 12.2% | 20.3% |
| EPS Diluted | 3.78 | -28.44 | 2.91 | 2.97 |
| % Growth | 113.3% | -1,077.3% | -2% | – |
| Operating Cash Flow | $907,000 | $757,000 | $636,000 | $384,306 |
| Capital Expenditures | -$92,000 | -$119,000 | -$87,000 | -$62,448 |
| Free Cash Flow | $907,000 | $638,000 | $549,000 | $321,858 |